INSP
Inspire Medical Systems, Inc. NYSE Listed May 3, 2018$59.50
+1.04%
vs $58.89
Mkt Cap $1.7B
52w Low $38.91
19.0% of range
52w High $147.03
50d MA $46.11
200d MA $68.64
P/E (TTM)
12.6x
EV/EBITDA
17.4x
P/B
2.2x
Debt/Equity
0.0x
ROE
18.6%
P/FCF
22.6x
RSI (14)
63.10
ATR (14)
$2.61
Beta
0.86
50d MA
$46.11
200d MA
$68.64
Avg Volume
1.1M
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
5500 Wayzata Boulevard · Golden Valley, MN 55416 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 3, 2026 | AMC | -0.24 | 0.14 | +159.3% | 52.22 | +22.9% | +22.8% | -6.3% | -2.0% | — | — | — |
| May 4, 2026 | AMC | -0.28 | 0.10 | +136.3% | 54.84 | -14.3% | -12.0% | -5.3% | -0.3% | -2.9% | -2.1% | — |
| Feb 11, 2026 | AMC | 0.69 | 1.65 | +139.1% | 67.94 | -18.3% | -12.2% | +0.2% | +1.1% | +2.5% | -3.4% | — |
| Nov 3, 2025 | AMC | -0.15 | 0.38 | +353.3% | 73.71 | +8.5% | +15.3% | -2.6% | +1.2% | -2.4% | +5.2% | — |
| Aug 4, 2025 | AMC | 0.22 | 0.45 | +104.5% | 129.95 | -31.7% | -32.4% | -10.8% | -1.8% | +2.7% | +0.6% | — |
| May 5, 2025 | AMC | -0.23 | 0.10 | +143.5% | 158.74 | -8.9% | +2.0% | -3.3% | -2.4% | -1.0% | +3.4% | — |
| Feb 10, 2025 | AMC | 0.74 | 1.15 | +55.4% | 180.99 | -5.8% | +1.7% | +1.6% | +0.1% | -0.8% | -3.0% | — |
| Nov 4, 2024 | AMC | 0.08 | 0.60 | +650.0% | 192.71 | +3.2% | +3.3% | +6.3% | -5.3% | -1.9% | +2.8% | — |
| Aug 6, 2024 | AMC | -0.14 | 0.32 | +328.6% | 147.01 | +17.0% | +28.1% | -0.4% | +2.9% | +1.1% | -1.6% | — |
| May 7, 2024 | AMC | -0.63 | -0.34 | +46.0% | 245.63 | -27.1% | -33.5% | +6.7% | -3.8% | -4.9% | -0.6% | — |
| Feb 6, 2024 | AMC | -0.09 | 0.49 | +644.4% | 226.00 | -0.4% | -10.5% | -0.1% | -3.5% | +0.8% | -4.2% | — |
| Nov 7, 2023 | AMC | -0.53 | -0.29 | +45.3% | 161.74 | -14.1% | -19.7% | -2.3% | -0.9% | -0.3% | +6.3% | — |
| Aug 1, 2023 | AMC | -0.51 | -0.41 | +19.6% | 290.93 | +0.2% | -4.5% | +2.3% | -2.5% | -4.2% | -7.7% | — |
| May 2, 2023 | AMC | -0.70 | -0.53 | +24.3% | 257.30 | +4.9% | +7.0% | -2.9% | +3.8% | +1.9% | +2.1% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 4 | Oppenheimer | Upgrade | Perform → Outperform | $85 | $52.22 | $64.16 | +22.9% | +22.8% | -6.3% | -2.0% | — | — |
| Jul 28 | UBS | Reiterates | Sell | $39 | $50.93 | $48.21 | -5.3% | +2.0% | -1.7% | -2.1% | +0.4% | +4.0% |
| Jun 23 | Evercore ISI | Downgrade | Outperform → In-line | $40 | $41.35 | $40.27 | -2.6% | +1.0% | +3.5% | +0.6% | +5.2% | -1.7% |
| May 22 | BofA Securities | Downgrade | Neutral → Underperform | $39 | $44.74 | $42.89 | -4.1% | -2.0% | -4.2% | +0.5% | +2.0% | -4.0% |
| May 5 | Piper Sandler | Downgrade | Overweight → Neutral | $55 | $54.84 | $47.00 | -14.3% | -12.0% | -5.3% | -0.3% | -2.9% | -2.1% |
| May 5 | BofA Securities | Downgrade | Buy → Neutral | $53 | $54.84 | $47.00 | -14.3% | -12.0% | -5.3% | -0.3% | -2.9% | -2.1% |
| Apr 15 | Truist | Maintains | Hold → Hold | — | $56.83 | $56.83 | +0.0% | -0.3% | -0.3% | +2.0% | -1.1% | -8.7% |
| Apr 13 | Mizuho | Maintains | Outperform → Outperform | — | $54.02 | $53.77 | -0.5% | +1.7% | +3.5% | -0.3% | -0.3% | +2.0% |
| Apr 10 | Stifel | Maintains | Buy → Buy | — | $56.69 | $56.00 | -1.2% | -4.7% | +1.7% | +3.5% | -0.3% | -0.3% |
| Apr 6 | Evercore ISI | Maintains | Outperform → Outperform | — | $54.99 | $56.41 | +2.6% | -1.5% | +0.5% | -1.9% | +6.2% | -4.7% |
| Mar 5 | Stifel | Maintains | Buy → Buy | — | $64.32 | $62.49 | -2.8% | -2.9% | +0.8% | -1.7% | -4.0% | +0.9% |
| Feb 13 | Wolfe Research | Downgrade | Outperform → Peer Perform | — | $59.65 | $59.64 | -0.0% | +0.2% | +1.1% | +2.5% | -3.4% | -0.4% |
| Feb 12 | Piper Sandler | Maintains | Overweight → Overweight | — | $67.94 | $55.52 | -18.3% | -12.2% | +0.2% | +1.1% | +2.5% | -3.4% |
| Feb 12 | Wells Fargo | Downgrade | Overweight → Equal Weight | — | $67.94 | $55.52 | -18.3% | -12.2% | +0.2% | +1.1% | +2.5% | -3.4% |
| Feb 12 | Jefferies | Maintains | Hold → Hold | — | $67.94 | $55.52 | -18.3% | -12.2% | +0.2% | +1.1% | +2.5% | -3.4% |
| Feb 12 | Mizuho | Maintains | Outperform → Outperform | — | $67.94 | $55.52 | -18.3% | -12.2% | +0.2% | +1.1% | +2.5% | -3.4% |
| Feb 12 | Truist | Maintains | Hold → Hold | — | $67.94 | $55.52 | -18.3% | -12.2% | +0.2% | +1.1% | +2.5% | -3.4% |
| Feb 12 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $67.94 | $55.52 | -18.3% | -12.2% | +0.2% | +1.1% | +2.5% | -3.4% |
| Feb 12 | Baird | Downgrade | Outperform → Neutral | — | $67.94 | $55.52 | -18.3% | -12.2% | +0.2% | +1.1% | +2.5% | -3.4% |
| Jan 27 | RBC Capital | Downgrade | Outperform → Sector Perform | — | $81.33 | $79.20 | -2.6% | +0.6% | +0.3% | -4.2% | -3.5% | -3.1% |
| Jan 14 | Wells Fargo | Maintains | Overweight → Overweight | — | $92.46 | $92.10 | -0.4% | +0.6% | +3.7% | -4.4% | +2.4% | +1.9% |
| Jan 8 | Truist | Maintains | Buy → Buy | — | $99.03 | $97.99 | -1.1% | -4.1% | +3.6% | -1.5% | -4.6% | +0.6% |
| Dec 23 | UBS | Maintains | Neutral → Neutral | — | $97.93 | $95.98 | -2.0% | -3.0% | +0.7% | -0.2% | -1.9% | -1.2% |
| Dec 17 | RBC Capital | Maintains | Outperform → Outperform | — | $115.51 | $117.95 | +2.1% | +2.4% | -19.4% | +1.3% | +1.4% | -3.0% |
| Dec 17 | Mizuho | Maintains | Outperform → Outperform | — | $115.51 | $117.95 | +2.1% | +2.4% | -19.4% | +1.3% | +1.4% | -3.0% |
| Dec 16 | JP Morgan | Maintains | Neutral → Neutral | — | $119.26 | $120.91 | +1.4% | -3.1% | +2.4% | -19.4% | +1.3% | +1.4% |
| Dec 8 | Oppenheimer | Upgrade | Perform → Outperform | — | $136.81 | $140.69 | +2.8% | +5.2% | -2.4% | -0.3% | -1.9% | -4.9% |
| Dec 8 | Piper Sandler | Maintains | Overweight → Overweight | — | $136.81 | $140.69 | +2.8% | +5.2% | -2.4% | -0.3% | -1.9% | -4.9% |
| Dec 4 | Baird | Maintains | Outperform → Outperform | — | $134.75 | $138.07 | +2.5% | +3.9% | -2.3% | +5.2% | -2.4% | -0.3% |
| Dec 2 | Morgan Stanley | Downgrade | Overweight → Equal Weight | — | $126.34 | $125.08 | -1.0% | +6.0% | +0.6% | +3.9% | -2.3% | +5.2% |
| Nov 26 | Truist | Upgrade | Hold → Buy | — | $130.39 | $130.61 | +0.2% | -2.3% | -2.3% | +1.6% | +6.0% | +0.6% |
| Nov 25 | Wolfe Research | Upgrade | Peer Perform → Outperform | — | $117.29 | $120.48 | +2.7% | +11.2% | -2.3% | -2.3% | +1.6% | +6.0% |
| Nov 24 | Stifel | Upgrade | Hold → Buy | — | $89.87 | $105.74 | +17.7% | +30.5% | +11.2% | -2.3% | -2.3% | +1.6% |
| Nov 4 | Piper Sandler | Maintains | Overweight → Overweight | — | $73.71 | $80.01 | +8.5% | +15.3% | -2.6% | +1.2% | -2.4% | +5.2% |
| Nov 4 | RBC Capital | Maintains | Outperform → Outperform | — | $73.71 | $80.01 | +8.5% | +15.3% | -2.6% | +1.2% | -2.4% | +5.2% |
| Nov 4 | JP Morgan | Maintains | Neutral → Neutral | — | $73.71 | $80.01 | +8.5% | +15.3% | -2.6% | +1.2% | -2.4% | +5.2% |
| Nov 4 | Truist | Maintains | Hold → Hold | — | $73.71 | $80.01 | +8.5% | +15.3% | -2.6% | +1.2% | -2.4% | +5.2% |
| Nov 4 | Wells Fargo | Upgrade | Equal Weight → Overweight | — | $73.71 | $80.01 | +8.5% | +15.3% | -2.6% | +1.2% | -2.4% | +5.2% |
| Oct 24 | Jefferies | Downgrade | Buy → Hold | — | $80.17 | $79.00 | -1.5% | -3.3% | +0.9% | -1.3% | -2.6% | -2.8% |
| Oct 15 | Truist | Maintains | Hold → Hold | — | $78.84 | $78.72 | -0.2% | +0.0% | -1.9% | +0.9% | +3.6% | +2.5% |
| Oct 7 | Evercore ISI | Maintains | Outperform → Outperform | — | $76.37 | $76.51 | +0.2% | +0.6% | +2.2% | +2.0% | -6.2% | +3.3% |
| Sep 22 | UBS | Downgrade | Buy → Neutral | — | $79.88 | $77.67 | -2.8% | -1.7% | -1.9% | +1.0% | -0.7% | -0.1% |
| Aug 15 | Leerink Partners | Maintains | Market Perform → Market Perform | — | $84.58 | $84.88 | +0.4% | +3.8% | +0.6% | +1.9% | +3.3% | -1.5% |
| Aug 5 | JP Morgan | Downgrade | Overweight → Neutral | — | $129.95 | $88.75 | -31.7% | -32.4% | -10.8% | -1.8% | +2.7% | +0.6% |
| Aug 5 | Stifel | Maintains | Hold → Hold | — | $129.95 | $88.75 | -31.7% | -32.4% | -10.8% | -1.8% | +2.7% | +0.6% |
| Aug 5 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $129.95 | $88.75 | -31.7% | -32.4% | -10.8% | -1.8% | +2.7% | +0.6% |
| Aug 5 | Leerink Partners | Maintains | Market Perform → Market Perform | — | $129.95 | $88.75 | -31.7% | -32.4% | -10.8% | -1.8% | +2.7% | +0.6% |
| Aug 5 | RBC Capital | Maintains | Outperform → Outperform | — | $129.95 | $88.75 | -31.7% | -32.4% | -10.8% | -1.8% | +2.7% | +0.6% |
| Aug 5 | UBS | Maintains | Buy → Buy | — | $129.95 | $88.75 | -31.7% | -32.4% | -10.8% | -1.8% | +2.7% | +0.6% |
| Aug 5 | KeyBanc Capital Markets | Downgrade | Overweight → Sector Weight | — | $129.95 | $88.75 | -31.7% | -32.4% | -10.8% | -1.8% | +2.7% | +0.6% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| May 15, 2026 | Rondoni JohnOff | See Remarks | Sell | 2,641 | $43.28 | $114K | 27,165 | +3.79% | +0.55% |
| May 14, 2026 | Rondoni JohnOff | See Remarks | Sell | 700 | $43.01 | $30K | 29,806 | +4.44% | -2.01% |
| May 8, 2026 | mcCormick ShawnDir | — | Sell | 696 | $45.31 | $32K | 27,712 | +1.64% | +4.44% |
8-K · 2.02
!! High
Inspire Medical Systems, Inc. -- 8-K 2.02: Earnings Results
Aug 3
8-K · 5.02
!!! Very High
Inspire Medical Systems, Inc. -- 8-K 5.02: Executive Change
Jul 24
8-K · 5.02
!!! Very High
Inspire Medical Systems, Inc. -- 8-K 5.02: Executive Change
Jul 22
8-K · 7.01
! Medium
Inspire Medical Systems, Inc. -- 8-K 7.01: Regulation FD Disclosure
Jun 26
8-K · 7.01
! Medium
Inspire Medical Systems, Inc. -- 8-K 7.01: Regulation FD Disclosure
Inspire Medical Systems is conducting investor outreach roadshow meetings in February-March 2026, with presentation materials available publicly, indicating management engagement with capital markets.
Feb 11
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Morgan Stanley | 2,519,524 | $232M | Added | Dec 2025 |
| 2 | Deerfield Management Company, L.p. | 2,703,238 | $139M | Added | Mar 2026 |
| 3 | Vanguard Portfolio Management Llc | 1,637,173 | $84M | New | Mar 2026 |
| 4 | Vanguard Capital Management Llc | 1,266,738 | $65M | New | Mar 2026 |
| 5 | D.e. Shaw & Co | 1,188,537 | $61M | Reduced | Mar 2026 |
| 6 | William Blair Investment Management, Llc | 1,137,384 | $59M | Reduced | Mar 2026 |
| 7 | Braidwell Lp | 540,890 | $50M | Reduced | Dec 2025 |
| 8 | Artisan Partners Limited Partnership | 780,575 | $40M | Reduced | Mar 2026 |
| 9 | Ubs Group Ag | 638,928 | $33M | Added | Mar 2026 |
| 10 | Soleus Capital Management, L.p. | 576,299 | $30M | Added | Mar 2026 |
| 11 | Jane Street Group, Llc | 277,199 | $26M | Added | Dec 2025 |
| 12 | Renaissance Technologies Llc | 469,968 | $24M | Added | Mar 2026 |
| 13 | Adar1 Capital Management, Llc | 405,197 | $21M | New | Mar 2026 |
| 14 | Citadel Advisors Llc | 394,076 | $20M | Reduced | Mar 2026 |
| 15 | Millennium Management | 386,146 | $20M | Added | Mar 2026 |
| 16 | Bnp Paribas Financial Markets | 319,758 | $16M | Reduced | Mar 2026 |
| 17 | Aqr Capital Management Llc | 308,662 | $16M | Added | Mar 2026 |
| 18 | Amundi | 256,830 | $13M | New | Mar 2026 |
| 19 | Frontier Capital Management Co Llc | 142,007 | $13M | Reduced | Dec 2025 |
| 20 | Royal Bank Of Canada | 252,971 | $13M | Added | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$1.72B
Enterprise Value
$1.44B
P/E (TTM)
12.61x
Forward P/E
31.94x
PEG Ratio
0.11x
P/B
2.24x
P/S
1.97x
P/FCF
22.56x
EV/EBITDA
17.38x
Shares Out
29.8M
Financials (TTM)
Revenue
$898.7M
Net Income
$135.0M
EBITDA
$83.1M
Free Cash Flow
$78.5M
Op Cash Flow
$117.0M
EPS Basic
$4.95
EPS Diluted
$4.62
EPS Forward
$1.86
Gross Margin
86.1%
Op Margin
6.0%
Net Margin
15.0%
Balance Sheet
Total Assets
$907.3M
Total Liab.
$126.2M
Total Equity
$781.2M
Cash
$308.3M
LT Debt
$0
Book Value/Sh
$26.60
Debt/Equity
0.04x
Current Ratio
6.08
Quick Ratio
4.56
Returns & Growth
ROE
18.6%
ROA
16.0%
ROIC
6.3%
Rev Growth YoY
+13.6%
EPS Growth YoY
+175.0%
Price Returns
2W
+15.9%
1M
+17.6%
3M
+29.2%
6M
-10.4%
12M
-23.6%
Technicals
52W High
$147.03
52W Low
$38.91
50d MA
$46.11
200d MA
$68.64
RSI (14)
63.10
ATR (14)
$2.61
Beta
0.86
Avg Volume
1.1M
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$91.33
High
$180.00
Low
$56.00
Median
$70.00
Data updated apr 25, 2026 3:47pm
· Source: financialmodelingprep.com